XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue - Summary of Revenues Disaggregated by Product Classification and Reportable Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Disaggregation Of Revenue [Line Items]        
Total revenue $ 34,995 $ 22,822 $ 57,292 $ 45,438
Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 11,783 11,770 21,885 21,744
Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 20,052 8,221 29,386 18,369
Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 3,160 2,831 6,021 5,325
Operating Segments [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 34,995 22,822 57,292 45,438
Operating Segments [Member] | Medical Device [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 27,907 16,304 44,103 33,708
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 5,410 5,455 9,971 10,477
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 7,474 6,714 15,383 15,613
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,445 2,628 4,746 4,862
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 12,578 1,507 14,003 2,756
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 7,088 6,518 13,189 11,730
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 6,373 6,315 11,914 11,267
Operating Segments [Member] | In Vitro Diagnostics [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue $ 715 $ 203 $ 1,275 $ 463